New Oral Medicine to Help Prevent COVID-19 After Exposure
Xocova / Zokovea (ensitrelvir) — oral COVID-19 post-exposure prophylaxis
The first FDA-labelled oral option for COVID-19 post-exposure prophylaxis (PEP).
Xocova (ensitrelvir) is the first pill approved in the United States to help prevent COVID-19 after contact with someone who has it.